[(Name of Issuer) Ordinary Shares/American Depositary Shares (Title of Class of Securities) 16938G 107 (CUSIP Number) December 31, 2009 (Date of Event Which Requires Filing of this Statement) ¨ ¨ x *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for]
[(Name of Issuer) Ordinary Shares/American Depositary Shares (Title of Class of Securities) 16938G 107 (CUSIP Number) December 31, 2009 (Date of Event Which Requires Filing of this Statement) ¨ ¨ x *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for]
[SINOVAC BIOTECH LTD. 10,000,000 Common Shares ($ 0.001 par value per Share) UNDERWRITING AGREEMENT January 27, 2010 UNDERWRITING AGREEMENT January 27, 2010 UBS Securities LLC c/o UBS Securities LLC 299 Park Avenue New York, New York 10171-0026 Piper Jaffray & Co. c/o Piper Jaffray & Co. U.S. Bancorp Center 800 Nicollet Mall Minneapolis, Minnesota 55402 as Managing Underwriters and Representatives] [1 - 32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o Incorporation by Reference 333-163165). 2 SINOVAC BIOTECH LTD.]
[SINOVAC BIOTECH LTD. 10,000,000 Common Shares ($ 0.001 par value per Share) UNDERWRITING AGREEMENT January 27, 2010 UNDERWRITING AGREEMENT January 27, 2010 UBS Securities LLC c/o UBS Securities LLC 299 Park Avenue New York, New York 10171-0026 Piper Jaffray & Co. c/o Piper Jaffray & Co. U.S. Bancorp Center 800 Nicollet Mall Minneapolis, Minnesota 55402 as Managing Underwriters and Representatives] [1 - 32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o Incorporation by Reference 333-163165). 2 SINOVAC BIOTECH LTD.]
[Sinovac Biotech Ltd. 10,000,000 Common Shares We are offering 10,000,000 common shares through this prospectus supplement and the accompanying prospectus. Our common shares are listed on the NASDAQ Global Market under the symbol "SVA." The last reported sale price of our common shares on January 27, 2010 was $6.11 per share. Investing in our common shares involves a high degree]
